Amneal Pharmaceuticals (AMRX) Stock Chart & Stock Price History $7.83 +0.01 (+0.13%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$7.82 0.00 (-0.06%) As of 08/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amneal Pharmaceuticals Stock Price Performance The Amneal Pharmaceuticals (AMRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 12.02%, with a year-to-date return of -1.14%. In the past month, the stock has decreased 6.45%, reflecting recent market activity. As of the latest close, Amneal Pharmaceuticals traded at $7.83 with a market cap of $2.45 billion and volume of 1.51 million shares. Five years ago, the stock traded at $4.33, representing a 80.83% increase over that period. At the time, it had a market cap of $1.30 billion and a volume of 743,832 shares. Receive AMRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.16%1 Month Performance-6.45%3 Month Performance-1.76%Year-To-Date Performance-1.14%1 Year Performance+12.02%5 Year Performance+80.83% AMRX Stock Chart for Saturday, August, 2, 2025 AMRX Chart by TradingView Amneal Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$7.82$7.83+0.13%$7.84$7.671.51 million shs$2.45 billion07/31/2025$8.07$7.82-3.10%$8.07$7.791.88 million shs$2.45 billion07/30/2025$8.09$8.07-0.25%$8.23$8.001.37 million shs$2.53 billion07/29/2025$8.17$8.09-0.98%$8.22$8.071.54 million shs$2.54 billion07/28/2025$8.06$8.17+1.36%$8.23$8.081.15 million shs$2.56 billion07/25/2025$8.00$8.06+0.75%$8.14$7.971.12 million shs$2.53 billion07/24/2025$8.07$8.00-0.87%$8.07$7.98764,787 shs$2.51 billion07/23/2025$7.96$8.07+1.38%$8.09$7.93851,883 shs$2.53 billion07/22/2025$7.91$7.96+0.63%$7.97$7.831.15 million shs$2.49 billion07/21/2025$7.97$7.91-0.75%$8.06$7.791.88 million shs$2.48 billion Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$8.24$7.97-3.28%$8.30$7.971.17 million shs$2.50 billion07/17/2025$8.26$8.24-0.24%$8.31$8.161.36 million shs$2.58 billion07/16/2025$8.27$8.26-0.12%$8.31$8.131.02 million shs$2.59 billion07/15/2025$8.42$8.27-1.78%$8.48$8.251.03 million shs$2.59 billion07/14/2025$8.33$8.42+1.08%$8.44$8.291.21 million shs$2.64 billion07/11/2025$8.39$8.33-0.72%$8.38$8.231.47 million shs$2.61 billion07/10/2025$8.33$8.39+0.72%$8.46$8.271.32 million shs$2.63 billion07/09/2025$8.25$8.33+0.97%$8.53$8.321.13 million shs$2.61 billion07/08/2025$8.41$8.25-1.90%$8.47$8.221.49 million shs$2.59 billion07/07/2025$8.56$8.41-1.75%$8.47$8.261.45 million shs$2.64 billion07/04/2025$8.56$8.56$8.46$8.26898,793 shs$2.68 billion07/03/2025$8.37$8.56+2.27%$8.46$8.26898,793 shs$2.68 billion07/02/2025$8.21$8.37+1.95%$8.42$8.171.53 million shs$2.62 billion07/01/2025$8.09$8.21+1.48%$8.41$8.071.94 million shs$2.57 billion Related Companies VRNA Stock Chart BBIO Stock Chart BPMC Stock Chart ROIV Stock Chart LEGN Stock Chart ELAN Stock Chart RGC Stock Chart RVMD Stock Chart GRFS Stock Chart TGTX Stock Chart Receive AMRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMRX Stock Alerts